SEC 13F Intelligence

First Wilshire Securities Management Inc / BSFA

First Wilshire Securities Management Inc’s Ani Pharmaceuticals Inc Position

Does First Wilshire Securities Management Inc own Ani Pharmaceuticals Inc (BSFA)? Not currently — the last reported position was 56.2K shares worth $3,028 in Q2 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$3,028
Q2 2023
Shares
56.2K
% of Portfolio
+1.04%
Quarters Held
11
position exited

Position History BSFA

Reported value by quarter
Q4 ’20: $5MQ4 ’20Q1 ’21: $8MQ2 ’21: $8MQ2 ’21Q3 ’21: $11MQ4 ’21: $15MQ4 ’21Q1 ’22: $9MQ2 ’22: $11MQ2 ’22Q3 ’22: $12MQ4 ’22: $14,541Q4 ’22Q1 ’23: $8,195Q2 ’23: $3,028Q2 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202356.2K$3,028+1.04%
Q1 2023206.3K$8,195+2.80%
Q4 2022361.4K$14,541+5.09%
Q3 2022367.3K$12M+4.78%
Q2 2022367.8K$11M+4.07%
Q1 2022327.9K$9M+3.24%
Q4 2021328.5K$15M+4.72%
Q3 2021333.7K$11M+3.63%
Q2 2021239.1K$8M+2.93%
Q1 2021220.0K$8M+2.97%
Q4 2020160.8K$5M+1.88%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See First Wilshire Securities Management Inc’s full portfolio or all institutional holders of BSFA.